|
- NULISA™ Platform | Immunoassay Analyzers - Alamar Biosciences
The NULISA™ platform is a proteomic liquid biopsy platform with attomolar sensitivity and high multiplexing Unlock the proteome with Alamar Biosciences
- NULISA: a proteomic liquid biopsy platform with attomolar . . . - Nature
Here we address these challenges with NUcleic acid Linked Immuno-Sandwich Assay (NULISA™), which improves the sensitivity of traditional proximity ligation assays by ~10,000-fold to attomolar
- NULISA: a novel proteomic liquid biopsy platform with attomolar . . .
We report a novel proteomic technology - NUcleic acid Linked Immuno-Sandwich Assay (NULISA™) - that incorporates a dual capture and release mechanism to suppress the assay background and improves the sensitivity of the proximity ligation assay by over 10,000-fold to the attomolar level
- Alamar Biosciences | Ultra-Sensitive Proteomics with the NULISA™ Platform
Discover Alamar Biosciences' NULISA™ Platform—an ultra-sensitive proteomics solution offering attomolar detection, broad dynamic range, and scalable multiplexing for biomarker discovery and quantification using advanced NGS technology
- NULISA - Esya Labs
Unlock Ultra-Sensitive Proteomics with NULISA™ In partnership with Alamar Biosciences, we deliver femtogram-level sensitivity, high multiplexing, and AI-driven insights —advancing biomarker discovery in neuroinflammation, oncology, and precision medicine
- NULISA™ Multiplex Assays - Biognosys
NULISA™ leverages a proprietary sequential immunocomplex capture and release mechanism, combined with advanced Next-Generation Sequencing (NGS), to achieve ultra-high sensitivity and scalable multiplexing
- Proteomics Company | Biotech Company | Alamar Biosciences
With best-in-class attomolar sensitivity and up to 12-log dynamic range, NULISA technology enables accurate detection of highly multiplexed protein biomarkers from a 25 µl liquid biopsy specimen
- NULISA: a proteomic liquid biopsy platform with attomolar . . . - Nature
Here we address these challenges with NUcleic acid Linked Immuno-Sandwich Assay (NULISATM), which improves the sensitivity of traditional proximity ligation assays by ~10,000-fold to attomolar
|
|
|